GALP(1-32) (human)



GALP(1-32) (human)

A1AA1P2PP2A3AA3H4HH4R5RR5G6GG6R7RR7G8GG8G9GG9W10WW10T11TT11L12LL12N13NN13S14SS14A15AA15G16GG16Y17YY17L18LL18L19LL19G20GG20P21PP21V22VV22L23LL23H24HH24L25LL25P26PP26Q27QQ27M28MM28G29GG29D30DD30Q31QQ31D32DD32

SMILES None
InChIKey QECBZQJTOLCHOO-NJXJWFHUSA-N
Sequence APAHRGRGGWTLNSAGYLLGPVLHLPQMGDQD

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

GALP(1-32) (human)

A1AA1P2PP2A3AA3H4HH4R5RR5G6GG6R7RR7G8GG8G9GG9W10WW10T11TT11L12LL12N13NN13S14SS14A15AA15G16GG16Y17YY17L18LL18L19LL19G20GG20P21PP21V22VV22L23LL23H24HH24L25LL25P26PP26Q27QQ27M28MM28G29GG29D30DD30Q31QQ31D32DD32

Drug properties

Molecular type Peptide
Physiological/Surrogate Surrogate
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.